Avadel Pharmaceuticals Directors Sell 1.1M Shares at $21/Share on 2026-02-12

Avadel Pharmaceuticals Plc (AVDL) has announced that Amin Naseem, a member of the company's board of directors, has sold 22,000 shares at a price of $21 per share on February 12, 2026. Additionally, Divis Gregory J, the company's Chief Executive Officer, has sold 211,105 shares and 10,000 shares at the same price on the same day. Other directors who have sold shares at $21 per share on February 12, 2026 include Ende Eric J (219,905 shares), Glass Geoffrey Michael (22,005 shares), McCamish Mark Anthony (22,000 shares), Chief Financial Officer MCHUGH THOMAS S (100,400 shares), Director Palczuk Linda (78,905 shares), Gen. Counsel & Corp. Secretary Seurer Jerad G. (23,496 shares), and Director Thornton Peter J. (115,060 shares).